Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory disorder of the pilosebaceous unit, often affecting and deforming intimate regions. HS is associated with severe pain, pruritus, and constant, purulent, malodorous discharge expected to impair sexual health of patients. Methods: We performed a cross-sectional, multicentric study involving 199 German patients from the health services research project “Epidemiology and Care in Acne inversa (EpiCAi).” The sexual health, HS severity, and quality of life of the studied group were evaluated using a specially designed questionnaire. Results: Regardless of gender, HS has an enormous impact on patients’ sexual health. The patients scored, on average, 28.8 ± 5.3 points on the Relation and Sexuality Scale (RSS). Multiple linear regression revealed that females and patients with Hurley III stage had higher sexual dysfunction (p = 0.012). Sexual dysfunction is associated with pain (β = 0.25), the number of active lesions, the affected areas (β = 0.14), and psychosocial aspects, including low quality of life (β = 0.404), stigmatization (β = 0.411), depression (β = 0.413), and anxiety (β = 0.300). Patients already see a substantial decrease in sexual frequency in the early stages of HS, while functional impairment and fear increase with the severity of the disease. Conclusion: Sexual health and management of its dysfunctions should be part of a holistic approach to HS patients.

1.
Krajewski
PK
,
Matusiak
L
,
von Stebut
E
,
Schultheis
M
, et al
.
Quality-of-Life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1,795 patients
.
Life
.
2021
;
11
(
1
):
34
. .
2.
Sabat
R
,
Jemec
GBE
,
Matusiak
L
,
Kimball
AB
,
Prens
E
,
Wolk
K
.
Hidradenitis suppurativa
.
Nat Rev Dis Primers
.
2020
;
6
(
1
):
18
. .
3.
Alavi
A
,
Farzanfar
D
,
Rogalska
T
,
Lowes
MA
,
Chavoshi
S
.
Quality of life and sexual health in patients with hidradenitis suppurativa
.
Int J Womens Dermatol
.
2018
;
4
(
2
):
74
9
. .
4.
Chernyshov
PV
,
Finlay
AY
,
Tomas-Aragones
L
,
Poot
F
,
Sampogna
F
,
Marron
SE
, et al
.
Quality of life in hidradenitis suppurativa: an update
.
Int J Environ Res Public Health
.
2021
;
18
(
11
):
6131
. .
5.
Zouboulis
CC
,
Desai
N
,
Emtestam
L
,
Hunger
RE
,
Ioannides
D
,
Juhász
I
, et al
.
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
.
J Eur Acad Dermatol Venereol
.
2015
;
29
(
4
):
619
44
. .
6.
Wlodarek
K
,
Glowaczewska
A
,
Matusiak
L
,
Szepietowski
JC
.
Psychosocial burden of Hidradenitis Suppurativa patients’ partners
.
J Eur Acad Dermatol Venereol
.
2020
;
34
(
8
):
1822
7
. .
7.
Deckers
IE
,
Kimball
AB
.
The handicap of hidradenitis suppurativa
.
Dermatol Clin
.
2016
;
34
(
1
):
17
22
. .
8.
Krajewski
PK
,
Matusiak
L
,
von Stebut
E
,
Schultheis
M
,
Kirschner
U
,
Nikolakis
G
, et al
.
Pain in hidradenitis suppurativa: a cross-sectional study of 1,795 patients
.
Acta Derm Venereol
.
2021
;
101
(
1
):
adv00364
. .
9.
Matusiak
L
,
Szczech
J
,
Kaaz
K
,
Lelonek
E
,
Szepietowski
JC
.
Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa
.
Acta Derm Venereol
.
2018
;
98
(
2
):
191
4
. .
10.
Glowaczewska
A
,
Szepietowski
JC
,
Matusiak
L
.
Prevalence and associated factors of alexithymia in patients with hidradenitis suppurativa: a cross-sectional study
.
Acta Derm Venereol
.
2021
;
101
(
11
):
adv00598
. .
11.
Matusiak
L
,
Bieniek
A
,
Szepietowski
JC
.
Psychophysical aspects of hidradenitis suppurativa
.
Acta Derm Venereol
.
2010
;
90
(
3
):
264
8
. .
12.
Schut
C
,
Dalgard
FJ
,
Bewley
A
,
Evers
AWM
,
Gieler
U
,
Lien
L
, et al
.
Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries
.
Br J Dermatol
.
2022
;
187
(
1
):
115
25
. .
13.
Rymaszewska
JE
,
Krajewski
PK
,
Szczech
J
,
Szepietowski
JC
.
Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients
.
Postepy Dermatol Alergol
.
2023
;
40
(
1
):
35
9
. .
14.
Sandhu
VK
,
Shah
M
,
Piguet
V
,
Alavi
A
.
The impact of hidradenitis suppurativa on work productivity and activity impairment
.
Br J Dermatol
.
2020
;
182
(
5
):
1288
90
. .
15.
Rymaszewska
JE
,
Krajewski
PK
,
Matusiak
L
,
Maj
J
, et al
.
Satisfaction with life and coping strategies among patients with hidradenitis suppurativa: a cross-sectional study
.
J Clin Med
.
2023
:
12
.
16.
Cuenca-Barrales
C
,
Montero-Vilchez
T
,
Szepietowski
JC
,
Matusiak
L
,
Molina-Leyva
A
.
Sexual impairment in patients with hidradenitis suppurativa: a systematic review
.
J Eur Acad Dermatol Venereol
.
2021
;
35
(
2
):
345
52
. .
17.
Kurek
A
,
Peters
EM
,
Chanwangpong
A
,
Sabat
R
,
Sterry
W
,
Schneider-Burrus
S
.
Profound disturbances of sexual health in patients with acne inversa
.
J Am Acad Dermatol
.
2012
;
67
(
3
):
422
8.e1
. .
18.
Kurek
A
,
Johanne Peters
EM
,
Sabat
R
,
Sterry
W
,
Schneider-Burrus
S
.
Depression is a frequent co-morbidity in patients with acne inversa
.
J Dtsch Dermatol Ges
.
2013
;
11
(
8
):
743
50
. .
19.
Sampogna
F
,
Abeni
D
,
Gieler
U
,
Tomas-Aragones
L
,
Lien
L
,
Titeca
G
, et al
.
Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries
.
Acta Derm Venereol
.
2017
;
97
(
4
):
478
82
. .
20.
Janse
IC
,
Deckers
IE
,
van der Maten
AD
,
Evers
AWM
,
Boer
J
,
van der Zee
HH
, et al
.
Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study
.
Br J Dermatol
.
2017
;
176
(
4
):
1042
7
. .
21.
Slyper
M
,
Strunk
A
,
Garg
A
.
Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis
.
Br J Dermatol
.
2018
;
179
(
2
):
502
3
. .
22.
Kluger
N
,
Sintonen
H
,
Ranta
M
,
Serlachius
M
.
Health-related quality of life of patients with hidradenitis suppurativa measured with the 15D instrument and comparison with the general population and patients with psoriasis
.
Skin Appendage Disord
.
2018
;
4
(
3
):
131
5
. .
23.
Cuenca-Barrales
C
,
Molina-Leyva
A
.
Risk factors of sexual dysfunction in patients with hidradenitis suppurativa: a cross-sectional study
.
Dermatology
.
2020
;
236
(
1
):
37
45
. .
24.
Garg
A
,
Neuren
E
,
Cha
D
,
Kirby
JS
,
Ingram
JR
,
Jemec
GBE
, et al
.
Evaluating patients’ unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project
.
J Am Acad Dermatol
.
2020
;
82
(
2
):
366
76
. .
25.
World Health Organization
.
Sexual health
.
WHO
;
2023
. Available from: https://www.who.int/health-topics/sexual-health#tab=tab_1.
26.
Carpenter
LM
.
Toward a social science of sexual satisfaction: commentary on “virginity lost, satisfaction gained? Physiological and psychological sexual satisfaction at heterosexual debut
.
J Sex Res
.
2010
;
47
(
4
):
395
8
. .
27.
Higgins
JA
,
Hirsch
JS
.
The pleasure deficit: revisiting the ”sexuality connection” in reproductive health
.
Int Fam Plan Perspect
.
2007
;
33
(
3
):
133
9
. .
28.
Busby
DM
,
Chiu
HY
,
Leonhardt
ND
,
Iliff
E
.
Sexual passion in committed relationships: measurement and conceptual issues
.
Fam Process
.
2019
;
58
(
3
):
734
48
. .
29.
Philpott
A
,
Knerr
W
,
Boydell
V
.
Pleasure and prevention: when good sex is safer sex
.
Reprod Health Matters
.
2006
;
14
(
28
):
23
31
. .
30.
Schultheis
M
,
Staubach
P
,
Grabbe
S
,
Ruckes
C
,
von Stebut
E
,
Kirschner
U
, et al
.
LAight® therapy is an effective treatment option to maintain long-term remission of Hurley I and II hidradenitis suppurativa: results from period B of RELIEVE, a multicenter randomized, controlled trial
.
Dermatology
.
2022
;
238
(
6
):
1092
103
. .
31.
Schultheis
M
,
Staubach
P
,
Nikolakis
G
,
Grabbe
S
,
Ruckes
C
,
von Stebut
E
, et al
.
LAight® therapy significantly enhances treatment efficacy of 16 Weeks of topical clindamycin solution in Hurley I and II hidradenitis suppurativa: results from period A of RELIEVE, a multicenter randomized, controlled trial
.
Dermatology
.
2022
;
238
(
3
):
476
86
. .
32.
Lenicura
.
The LAight therapy: lenicura
.
2018
. Available from: https://www.lenicura.com/.
33.
Schultheis
M
,
Staubach-Renz
P
,
Grabbe
S
,
Hennig
K
,
Khoury
F
,
Nikolakis
G
, et al
.
Can hidradenitis suppurativa patients classify their lesions by means of a digital lesion identification scheme
.
J Dtsch Dermatol Ges
.
2023
;
21
(
1
):
27
32
. .
34.
Berglund
G
,
Nystedt
M
,
Bolund
C
,
Sjoden
PO
,
Rutquist
LE
.
Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study
.
J Clin Oncol
.
2001
;
19
(
11
):
2788
96
. .
35.
Tavallaii
SA
,
Fathi-Ashtiani
A
,
Nasiri
M
,
Assari
S
,
Maleki
P
,
Einollahi
B
.
Correlation between sexual function and postrenal transplant quality of life: does gender matter
.
J Sex Med
.
2007
;
4
(
6
):
1610
8
. .
36.
Chien
CW
,
Bagraith
KS
,
Khan
A
,
Deen
M
,
Syu
JJ
,
Strong
J
.
Establishment of cutpoints to categorize the severity of chronic pain using composite ratings with Rasch analysis
.
Eur J Pain
.
2017
;
21
(
1
):
82
91
. .
37.
Chernyshov
PV
,
Zouboulis
CC
,
Tomas-Aragones
L
,
Jemec
GB
,
Svensson
A
,
Manolache
L
, et al
.
Quality of life measurement in hidradenitis suppurativa: position statement of the European academy of dermatology and venereology task forces on quality of life and patient-oriented outcomes and acne, rosacea and hidradenitis suppurativa
.
J Eur Acad Dermatol Venereol
.
2019
;
33
(
9
):
1633
43
. .
38.
Finlay
AY
,
Khan
GK
.
Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use
.
Clin Exp Dermatol
.
1994
;
19
(
3
):
210
6
. .
39.
Dimitrov
D
,
Szepietowski
JC
.
Instruments to assess stigmatization in dermatology
.
Postepy Hig Med Dosw
.
2017
;
71
(
0
):
901
5
. .
40.
Zigmond
AS
,
Snaith
RP
.
The hospital anxiety and depression scale
.
Acta Psychiatr Scand
.
1983
;
67
(
6
):
361
70
. .
41.
Alya
A
,
Saleh
A
,
Sawsan
A
,
Louai
S
.
Psychosocial implications and quality of life in patients with hidradenitis suppurativa compared to those with atopic dermatitis and psoriasis: a cross-sectional case-control study
.
Dermatol Pract Concept
.
2023
:
13
.
42.
Sampogna
F
,
Fania
L
,
Mazzanti
C
,
Pallotta
S
,
Panebianco
A
,
Mastroeni
S
, et al
.
The impact of hidradenitis suppurativa on general health is higher than that of hypertension, congestive heart failure, type 2 diabetes, myocardial infarction and depression
.
J Eur Acad Dermatol Venereol
.
2020
;
34
(
8
):
e386
8
. .
43.
Mortimore
AM
,
Bullen
A
,
McMeniman
EK
.
The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction
.
Australas J Dermatol
.
2022
;
63
(
4
):
505
8
. .
44.
Kazemi-Saleh
D
,
Pishgoo
B
,
Farrokhi
F
,
Fotros
A
,
Assari
S
.
Sexual function and psychological status among males and females with ischemic heart disease
.
J Sex Med
.
2008
;
5
(
10
):
2330
7
. .
45.
Cuenca-Barrales
C
,
Ruiz-Villaverde
R
,
Molina-Leyva
A
.
Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study
.
J Clin Med
.
2019
;
8
(
4
):
532
. .
46.
Prens
LM
,
Huizinga
J
,
Janse
IC
,
Horvath
B
.
Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study
.
J Eur Acad Dermatol Venereol
.
2019
;
33
(
10
):
1941
6
. .
You do not currently have access to this content.